Use of genetically modified rat models for translational medicine

Drug Discovery Today

Volumn 13, Issue 11-12, 2008, Pages 488-494

  Cozzi, Jean ^a   Fraichard, Alexandre ^a   Thiam, Kader ^a  

^a genOway   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL CHROMOSOME; CHEMICAL MUTAGENESIS; DISEASE MODEL; DRUG RESEARCH; GENE OVEREXPRESSION; GENE REPRESSION; MEDICAL RESEARCH; NONHUMAN; RAT; RECOMBINANT DNA TECHNOLOGY; REVIEW; TRANSGENE; TRANSGENIC RAT; TRANSGENICS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; DRUG INDUSTRY; GENE EXPRESSION; GENE TARGETING; HUMANS; RATS; TRANSGENES;

EID: 44649128512     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.03.021     Document Type: Review

References (58)

1. Zambrowicz B.P., and Sands A.T. Knockouts model the 100 best-selling drugs - will they model the next 100?. Nat. Rev. Drug Discov. 2 (2003) 38-51
2. Gill III T.J., et al. The rat as an experimental animal. Science 245 (1989) 269-276
3. Mullins J.J., et al. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344 (1990) 541-544
4. Hammer R.E., et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63 (1990) 1099-1112
5. Bolon B. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research. Basic Clin. Pharmacol. Toxicol. 95 (2004) 154-161
6. Tesson L., et al. Transgenic modifications of the rat genome. Transgenic Res. 14 (2005) 531-546
7. Ganten D., et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 7806-7810
8. Keppler O.T., et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 195 (2002) 719-736
9. Goffinet C., et al. HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 1015-1020
10. von Horsten S., et al. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12 (2003) 617-624
11. Herrera V.L., et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat. Med. 5 (1999) 1383-1389
12. Wall R.J. Pronuclear microinjection. Cloning Stem Cells 3 (2001) 209-220
13. Walton E.A., et al. Ovulation response and fertilization failure in immature rats induced to superovulate. J. Reprod. Fertil. 67 (1983) 91-96
14. Charreau B., et al. Transgenesis in rats: technical aspects and models. Transgenic Res. 5 (1996) 223-234
15. van den Brandt J., et al. Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39 (2004) 94-99
16. Lois C., et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295 (2002) 868-872
17. Michalkiewicz M., et al. Efficient transgenic rat production by a lentiviral vector. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H881-H894
18. Pfeifer A., et al. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2140-2145
19. Dann C.T. New technology for an old favorite: lentiviral transgenesis and RNAi in rats. Transgenic Res. 16 (2007) 571-580
20. Lee J.Y., et al. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J. Biol. Chem. 281 (2006) 2649-2653
21. West A.G., et al. Insulators: many functions, many mechanisms. Genes Dev. 16 (2002) 271-288
22. Schedl A., et al. A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 362 (1993) 258-261
23. Takahashi R., et al. Generation of transgenic rats with YACs and BACs: preparation procedures and integrity of microinjected DNA. Exp. Anim. 49 (2000) 229-233
24. Fujiwara Y., et al. Position-independent and high-level expression of human alpha-lactalbumin in the milk of transgenic rats carrying a 210-kb YAC DNA. Mol. Reprod. Dev. 47 (1997) 157-163
25. Hochi S., et al. Secretion of bovine alpha-lactalbumin into the milk of transgenic rats. Mol. Reprod. Dev. 33 (1992) 160-164
26. Vilotte J.L., et al. Efficient tissue-specific expression of bovine alpha-lactalbumin in transgenic mice. Eur. J. Biochem. 186 (1989) 43-48
27. Bleck G.T., and Bremel R.D. Variation in expression of a bovine alpha-lactalbumin transgene in milk of transgenic mice. J. Dairy Sci. 77 (1994) 1897-1904
28. Moreira P.N., et al. Efficient generation of transgenic mice with intact yeast artificial chromosomes by intracytoplasmic sperm injection. Biol. Reprod. 71 (2004) 1943-1947
29. Schedl A., et al. A method for the generation of YAC transgenic mice by pronuclear microinjection. Nucleic Acids Res. 21 (1993) 4783-4787
30. Abe K., et al. Establishment of an efficient BAC transgenesis protocol and its application to functional characterization of the mouse Brachyury locus. Exp. Anim. 53 (2004) 311-320
31. Osada T., et al. Production of inbred and hybrid transgenic mice carrying large (>200 kb) foreign DNA fragments by intracytoplasmic sperm injection. Mol. Reprod. Dev. 72 (2005) 329-335
32. Hirabayash M., et al. Offspring derived from intracytoplasmic injection of transgenic rat sperm. Transgenic Res. 11 (2002) 221-228
33. Kato M., et al. Production of transgenic rats by ooplasmic injection of spermatogenic cells exposed to exogenous DNA: a preliminary study. Mol. Reprod. Dev. 69 (2004) 153-158
34. Hirabayashi M., et al. Factors affecting production of transgenic rats by ICSI-mediated DNA transfer: effects of sonication and freeze-thawing of spermatozoa, rat strains for sperm and oocyte donors, and different constructs of exogenous DNA. Mol. Reprod. Dev. 70 (2005) 422-428
35. Lakso M., et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6232-6236
36. Sato Y., et al. Establishment of Cre/LoxP recombination system in transgenic rats. Biochem. Biophys. Res. Commun. 319 (2004) 1197-1202
37. Ueda S., et al. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis 27 (2006) 2497-2510
38. Ajiki T., et al. Composite tissue transplantation in rats: fusion of donor muscle to the recipient site. Transplant. Proc. 37 (2005) 208-209
39. Means A.L., et al. Keratin 19 gene drives Cre recombinase expression throughout the early postimplantation mouse embryo. Genesis 42 (2005) 23-27
40. Gong S., et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J. Neurosci. 27 (2007) 9817-9823
41. Lemberger T., et al. Expression of Cre recombinase in dopaminoceptive neurons. BMC Neurosci. 8 (2007) 4
42. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
43. Braudeau C., et al. Generation of heme oxygenase-1-transgenic rats. Exp. Biol. Med. (Maywood) 228 (2003) 466-471
44. Tesson L., et al. Endothelial expression of Fas ligand in transgenic rats under the temporal control of a tetracycline-inducible system. Transplant. Proc. 31 (1999) 1533-1534
45. Bouchet D., et al. Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels. Mol. Med. 8 (2002) 612-623
46. Schonig K., et al. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 30 (2002) e134
47. Flavell D.M., et al. Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons. EMBO J. 15 (1996) 3871-3879
48. Ogawa S., et al. Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor alpha and beta pathways. J. Biol. Chem. 275 (2000) 21372-21379
49. Langenickel T.H., et al. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 4735-4740
50. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
51. Gao X., and Zhang P. Transgenic RNA interference in mice. Physiology (Bethesda) 22 (2007) 161-166
52. Hasuwa H., et al. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532 (2002) 227-230
53. Dann C.T., et al. Heritable and stable gene knockdown in rats. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11246-11251
54. Zan Y., et al. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat. Biotechnol. 21 (2003) 645-651
55. Smits B.M., et al. Target-selected mutagenesis of the rat. Genomics 83 (2004) 332-334
56. Zhou Q., et al. Generation of fertile cloned rats by regulating oocyte activation. Science 302 (2003) 1179
57. Hamra F.K., et al. Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14931-14936
58. Ryu B.Y., et al. Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells. J. Androl. 28 (2007) 353-360